0001938064-22-000002.txt : 20220715 0001938064-22-000002.hdr.sgml : 20220715 20220715165508 ACCESSION NUMBER: 0001938064-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220715 DATE AS OF CHANGE: 20220715 EFFECTIVENESS DATE: 20220715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Visiox Pharma, LLC CENTRAL INDEX KEY: 0001938064 IRS NUMBER: 821873866 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-452677 FILM NUMBER: 221087430 BUSINESS ADDRESS: STREET 1: 303 SOUTH BROADWAY STREET 2: STE. 125 CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9149872876 MAIL ADDRESS: STREET 1: 303 SOUTH BROADWAY STREET 2: STE. 125 CITY: TARRYTOWN STATE: NY ZIP: 10591 D 1 primary_doc.xml X0708 D LIVE 0001938064 Visiox Pharma, LLC 303 SOUTH BROADWAY STE. 125 TARRYTOWN NY NEW YORK 10591 9149872876 DELAWARE Ameribridge Health LLC None Limited Liability Company true 2019 Michael Derby 303 South Broadway Suite 125 Tarrytown NY NEW YORK 10591 Executive Officer Executive Chairman of Issuer Zachary Rome 303 South Broadway Suite 125 Tarrytown NY NEW YORK 10591 Director Director of Issuer Ryan Bleeks 303 South Broadway Suite 125 Tarrytown NY NEW YORK 10591 Executive Officer Chief Executive Officer of Issuer Pharmaceuticals Decline to Disclose 06b false 2022-06-30 false true false 25000 3000000 1300000 1700000 false 14 0 0 500000 true The Issuer will pay an approximate amount of $500,000 for salary expenses of the Chief Executive Officer and management fees to the Manager of the Issuer, of which the Executive Chairman and Director are Managers. false Visiox Pharma, LLC Alexandra Schulz Alexandra Schulz Counsel of Issuer 2022-07-15